Surgical resection of thymoma still represents the first choice of treatment

Thoracic and Cardiovascular Surgeon

Volumn 60, Issue 2, 2012, Pages 145-149

  Ried, M ^a   Guth, H ^a   Potzger, T ^a   Diez, C ^a   Neu, R ^a   Schalke, B ^a   Hofmann, H S ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

myasthenia gravis; thymic carcinoma; thymoma; thymus hyperplasia

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CLINICAL ARTICLE; COMORBIDITY; DISEASE FREE INTERVAL; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; MALE; MYASTHENIA GRAVIS; OVERALL SURVIVAL; PRIORITY JOURNAL; SURVIVAL RATE; THYMOMA; THYMUS SURGERY; TREATMENT INDICATION;

ADULT; AGED; AGED, 80 AND OVER; DISEASE-FREE SURVIVAL; FEMALE; GERMANY; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MYASTHENIA GRAVIS; NEOPLASM RECURRENCE, LOCAL; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; THYMECTOMY; THYMOMA; THYMUS NEOPLASMS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84858400887     PISSN: 01716425     EISSN: 14391902     Source Type: Journal    
DOI: 10.1055/s-0030-1271010     Document Type: Article

References (25)

1. Detterbeck FC, Parson AM. Thymic tumors. Ann Thorac Surg: 2004; 77 1860 1869 (Pubitemid 38530055)
2. Masaoka A, Monden Y, Nakahara K., et al. Follow-up study of thymomas with special reference to their clinical stages. Cancer: 1981; 48 2485 2492 (Pubitemid 12228012)
3. Rosai J, Sobin L. Histological typing of tumours of the thymus. In: World Health Organization, ed. International histological Classification of Tumours. Heidelberg Springer Verlag: 1999; 1 16
4. Lopez-Cano M, Ponseti-Bosch JM, Espin-Basany E, Sanchez-Garcia JL, Armengol-Carrasco M. Clinical and pathologic predictors of outcome in thymoma-associated myasthenia gravis. Ann Thorac Surg: 2003; 76 1643 1649 (Pubitemid 37378327)
5. Drachmann DB. Myasthenia gravis. N Engl J Med: 1994; 330 1797 1810
6. Kondo K, Monden Y. Therapy for thymic epithelial tumors: a clinical study of 1320 patients from Japan. Ann Thorac Surg: 2003; 76 878 885
7. Kattach H, Anastasiadis K, Cleuziou J., et al. Transsternal thymectomy for myasthenia gravis: surgical outcome. Ann Thorac Surg: 2006; 81 305 308 (Pubitemid 41815424)
8. Okereke IC, Kesler KA, Morad MH., et al. Prognostic indicators after surgery for thymoma. Ann Thorac Surg: 2010; 89 1071 1079
9. Hejna M, Haberl I, Raderer M. Nonsurgical management of malignant thymoma. Cancer: 1999; 85 1871 1884 (Pubitemid 29202759)
10. Rajan A, Giaccone G. Treatment of advanced thymoma and thymic carcinoma. Curr Treatment Options Oncol: 2008; 9 277 287
11. Cardillo G, Carleo F, Giunti R., et al. Predictors of survival in patients with locally advanced thymoma and thymic carcinoma (Masaoka stages III and IVa). Eur J Cardiothoracic Surg: 2010; 37 819 823
12. Marienhagen J, Schalke B, Aebert H, Held P, Eilles C, Bogdahn U. Somatostatin receptor scintigraphy in thymoma imaging method and clinical application. Pathol Res Pract: 1999; 195 8 575 581 (Pubitemid 29405762)
13. Wilkins KB, Sheikh E, Green R., et al. Clinical and pathologic predictors of survival in patients with thymoma. Ann Surg: 1999; 230 4 562 574 (Pubitemid 30191851)
14. Thomas CR, Wright CD, Loehrer PJ. Thymoma: state of the art. J Clin Oncol: 1999; 17 2280 2289 (Pubitemid 29318862)
15. Rea F, Marulli G, Girardi R., et al. Long-term survival and prognostic factors in thymic epithelial tumours. Eur J Cardiothoracic Surg: 2004; 26 412 418 (Pubitemid 39024669)
16. Venuta F, Anile M, Diso D., et al. Thymoma and thymic carcinoma. Eur J Cardiothoracic Surg: 2010; 37 13 25
17. Hosaka Y, Tsuchida M, Toyabe S, Umezu H, Eimoto T, Hayashi J. Masaoka stage and histologic grade predict prognosis in patients with thymic carcinoma. Ann Thorac Surg: 2010; 89 912 917
18. Regnard JF, Magdeleinat P, Dromer C., et al. Prognostic factors and long-term results after thymoma resection: a series of 307 patients. J Thorac Cardiovasc Surg: 1996; 112 2 376 384 (Pubitemid 26301849)
19. Lardinois D, Rechsteiner R, Läng RH., et al. Prognostic relevance of Masaoka and Müller-Hermelink classification in patients with thymic tumors. Ann Thorac Surg: 2000; 69 1550 1555 (Pubitemid 30434891)
20. Margaritora S, Cesario A, Cusumano G., et al. Thirty-five-year follow-up analysis of clinical and pathologic outcomes of thymoma surgery. Ann Thorac Surg: 2010; 89 245 252
21. Kim BK, Cho BC, Choi HJ., et al. A single institutional experience of surgically resected thymic epithelial tumors over 10 years - clinical outcomes and clinicopathologic features. Oncol Reports: 2008; 19 1525 1531
22. Ishikawa Y, Matsuguma H, Nakahara R., et al. Multimodality therapy for patients with invasive thymoma disseminated into the pleural cavity: the potential role of extrapleural pneumonectomy. Ann Thorac Surg: 2009; 88 952 957
23. Refaely Y, Simansky DA, Paley M, Gottfried M, Yellin A. Resection and perfusion thermochemotherapy: a new approach for the treatment of thymic malignancies with pleural spread. Ann Thorac Surg: 2001; 72 366 370 (Pubitemid 32727129)
24. De Bree E, van Ruth S, Baas B., et al. Cytoreductive surgery and intraoperative hyperthermic intrathoracic chemotherapy in patients with malignant pleural mesothelioma or pleural metastases of thymoma. Chest: 2002; 121 480 487 (Pubitemid 34132987)
25. Hofmann HS, Wiebe K. Cytoreductive surgery and hyperthermic intrathoracic chemotherapy perfusion. Chirurg: 2010; 81 6 557 562